» Articles » PMID: 35887931

Main Barriers to the Introduction of a Home Haemodialysis Programme in Poland: A Review of the Challenges for Implementation and Criteria for a Successful Programme

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Jul 27
PMID 35887931
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Home dialysis in Poland is restricted to the peritoneal dialysis (PD) modality, with the majority of dialysis patients treated using in-centre haemodialysis (ICHD). Home haemodialysis (HHD) is an additional home therapy to PD and provides an attractive alternative to ICHD that combines dialysis with social distancing; eliminates transportation needs; and offers clinical, economic, and quality of life benefits. However, HHD is not currently provided in Poland. This review was performed to provide an overview of the main barriers to the introduction of a HHD programme in Poland.

Main Findings: The main high-level barrier to introducing HHD in Poland is the absence of specific health legislation required for clinician prescribing of HHD. Other barriers to overcome include clear definition of reimbursement, patient training and education (including infrastructure and experienced personnel), organisation of logistics, and management of complications. Partnering with a large care network for HHD represents an alternative option to payers for the provision of a new HHD service. This may reduce some of the barriers which need to be overcome when compared with the creation of a new HHD service and its supporting network due to the pre-existing infrastructure, processes, and staff of a large care network.

Conclusions: Provision of HHD is not solely about the provision of home treatment, but also the organisation and definition of a range of support services that are required to deliver the service. HHD should be viewed as an additional, complementary option to existing dialysis modalities which enables choice of modality best suited to a patient's needs.

References
1.
Ludlow M, George C, Hawley C, Mathew T, Agar J, Kerr P . How Australian nephrologists view home dialysis: results of a national survey. Nephrology (Carlton). 2011; 16(4):446-52. DOI: 10.1111/j.1440-1797.2010.01403.x. View

2.
Rydell H, Ivarsson K, Almquist M, Clyne N, Segelmark M . Fewer hospitalizations and prolonged technique survival with home hemodialysis- a matched cohort study from the Swedish Renal Registry. BMC Nephrol. 2020; 20(1):480. PMC: 6937632. DOI: 10.1186/s12882-019-1644-z. View

3.
Marshall M, Polkinghorne K, Kerr P, Hawley C, Agar J, McDonald S . Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations. Am J Kidney Dis. 2015; 67(4):617-28. DOI: 10.1053/j.ajkd.2015.09.025. View

4.
Vanholder R, Davenport A, Hannedouche T, Kooman J, Kribben A, Lameire N . Reimbursement of dialysis: a comparison of seven countries. J Am Soc Nephrol. 2012; 23(8):1291-8. DOI: 10.1681/ASN.2011111094. View

5.
Yeoh E, Wong M, Wong E, Yam C, Poon C, Chung R . Benefits and limitations of implementing Chronic Care Model (CCM) in primary care programs: A systematic review. Int J Cardiol. 2018; 258:279-288. DOI: 10.1016/j.ijcard.2017.11.057. View